Risks of Mitral Valve Replacement and Mitral Valve Replacement with Coronary Artery Bypass

James A. Magovern, John L. Pennock, David Campbell, William S. Pierce, John A. Waldhausen

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

One hundred thirty consecutive patients who underwent mitral valve replacement (MVR) or MVR with coronary artery bypass grafting (CABG) using cold crystalloid cardioplegic solution were analyzed to determine operative mortality and risk factors. Twenty-eight patients had mitral stenosis (MS), 37 had mitral regurgitation (MR), 37 had mixed MS and MR, 23 had MR with coronary artery disease (CAD), and 5 had MS with CAD. Preoperative pulmonary artery pressure, pulmonary capillary wedge pressure, and cardiac index were not different among groups, but patients with MR and CAD had a significantly higher left ventricular end-diastolic pressure (LVEDP) and a significantly lower ejection fraction than other groups. Mortality was 7.1% for patients with MS, 5.4% for MR, 8.1% for mixed MS and MR, 0 for MS with CAD, and 21.7% for MR and CAD. Overall mortality was 9.2%. Eleven patients had emergency operations for cardiogenic shock with a mortality of 45%. Nineteen additional patients in New York Heart Association (NYHA) Functional Class IV had MVR or MVR plus CABG with a mortality of 26%. Sixteen patients required intraaortic balloon pump assistance, and 9 survived. Four patients with MR and CAD required the left ventricular assist device, and 3 survived. Excluding patients who had emergency operations, overall mortality was 5.8%. Excluding patients who had emergency operations and patients in NYHA Functional Class IV, overall mortality was 2%. Factors associated with death were cardiogenic shock, NYHA Class IV, LVEDP greater than 15 mm Hg (16% mortality), and age greater than 60 years (15% mortality).

Original languageEnglish (US)
Pages (from-to)346-352
Number of pages7
JournalAnnals of Thoracic Surgery
Volume39
Issue number4
DOIs
StatePublished - Jan 1 1985

Fingerprint

Mitral Valve
Coronary Artery Bypass
Mitral Valve Insufficiency
Mitral Valve Stenosis
Mortality
Coronary Artery Disease
Emergencies
Cardiogenic Shock
Blood Pressure
Pulmonary Wedge Pressure
Heart-Assist Devices
Pulmonary Artery
Pressure

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Magovern, J. A., Pennock, J. L., Campbell, D., Pierce, W. S., & Waldhausen, J. A. (1985). Risks of Mitral Valve Replacement and Mitral Valve Replacement with Coronary Artery Bypass. Annals of Thoracic Surgery, 39(4), 346-352. https://doi.org/10.1016/S0003-4975(10)62628-8
Magovern, James A. ; Pennock, John L. ; Campbell, David ; Pierce, William S. ; Waldhausen, John A. / Risks of Mitral Valve Replacement and Mitral Valve Replacement with Coronary Artery Bypass. In: Annals of Thoracic Surgery. 1985 ; Vol. 39, No. 4. pp. 346-352.
@article{ab0f4d15dcfb49d4bb3a92e3183086f2,
title = "Risks of Mitral Valve Replacement and Mitral Valve Replacement with Coronary Artery Bypass",
abstract = "One hundred thirty consecutive patients who underwent mitral valve replacement (MVR) or MVR with coronary artery bypass grafting (CABG) using cold crystalloid cardioplegic solution were analyzed to determine operative mortality and risk factors. Twenty-eight patients had mitral stenosis (MS), 37 had mitral regurgitation (MR), 37 had mixed MS and MR, 23 had MR with coronary artery disease (CAD), and 5 had MS with CAD. Preoperative pulmonary artery pressure, pulmonary capillary wedge pressure, and cardiac index were not different among groups, but patients with MR and CAD had a significantly higher left ventricular end-diastolic pressure (LVEDP) and a significantly lower ejection fraction than other groups. Mortality was 7.1{\%} for patients with MS, 5.4{\%} for MR, 8.1{\%} for mixed MS and MR, 0 for MS with CAD, and 21.7{\%} for MR and CAD. Overall mortality was 9.2{\%}. Eleven patients had emergency operations for cardiogenic shock with a mortality of 45{\%}. Nineteen additional patients in New York Heart Association (NYHA) Functional Class IV had MVR or MVR plus CABG with a mortality of 26{\%}. Sixteen patients required intraaortic balloon pump assistance, and 9 survived. Four patients with MR and CAD required the left ventricular assist device, and 3 survived. Excluding patients who had emergency operations, overall mortality was 5.8{\%}. Excluding patients who had emergency operations and patients in NYHA Functional Class IV, overall mortality was 2{\%}. Factors associated with death were cardiogenic shock, NYHA Class IV, LVEDP greater than 15 mm Hg (16{\%} mortality), and age greater than 60 years (15{\%} mortality).",
author = "Magovern, {James A.} and Pennock, {John L.} and David Campbell and Pierce, {William S.} and Waldhausen, {John A.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1016/S0003-4975(10)62628-8",
language = "English (US)",
volume = "39",
pages = "346--352",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

Magovern, JA, Pennock, JL, Campbell, D, Pierce, WS & Waldhausen, JA 1985, 'Risks of Mitral Valve Replacement and Mitral Valve Replacement with Coronary Artery Bypass', Annals of Thoracic Surgery, vol. 39, no. 4, pp. 346-352. https://doi.org/10.1016/S0003-4975(10)62628-8

Risks of Mitral Valve Replacement and Mitral Valve Replacement with Coronary Artery Bypass. / Magovern, James A.; Pennock, John L.; Campbell, David; Pierce, William S.; Waldhausen, John A.

In: Annals of Thoracic Surgery, Vol. 39, No. 4, 01.01.1985, p. 346-352.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Risks of Mitral Valve Replacement and Mitral Valve Replacement with Coronary Artery Bypass

AU - Magovern, James A.

AU - Pennock, John L.

AU - Campbell, David

AU - Pierce, William S.

AU - Waldhausen, John A.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - One hundred thirty consecutive patients who underwent mitral valve replacement (MVR) or MVR with coronary artery bypass grafting (CABG) using cold crystalloid cardioplegic solution were analyzed to determine operative mortality and risk factors. Twenty-eight patients had mitral stenosis (MS), 37 had mitral regurgitation (MR), 37 had mixed MS and MR, 23 had MR with coronary artery disease (CAD), and 5 had MS with CAD. Preoperative pulmonary artery pressure, pulmonary capillary wedge pressure, and cardiac index were not different among groups, but patients with MR and CAD had a significantly higher left ventricular end-diastolic pressure (LVEDP) and a significantly lower ejection fraction than other groups. Mortality was 7.1% for patients with MS, 5.4% for MR, 8.1% for mixed MS and MR, 0 for MS with CAD, and 21.7% for MR and CAD. Overall mortality was 9.2%. Eleven patients had emergency operations for cardiogenic shock with a mortality of 45%. Nineteen additional patients in New York Heart Association (NYHA) Functional Class IV had MVR or MVR plus CABG with a mortality of 26%. Sixteen patients required intraaortic balloon pump assistance, and 9 survived. Four patients with MR and CAD required the left ventricular assist device, and 3 survived. Excluding patients who had emergency operations, overall mortality was 5.8%. Excluding patients who had emergency operations and patients in NYHA Functional Class IV, overall mortality was 2%. Factors associated with death were cardiogenic shock, NYHA Class IV, LVEDP greater than 15 mm Hg (16% mortality), and age greater than 60 years (15% mortality).

AB - One hundred thirty consecutive patients who underwent mitral valve replacement (MVR) or MVR with coronary artery bypass grafting (CABG) using cold crystalloid cardioplegic solution were analyzed to determine operative mortality and risk factors. Twenty-eight patients had mitral stenosis (MS), 37 had mitral regurgitation (MR), 37 had mixed MS and MR, 23 had MR with coronary artery disease (CAD), and 5 had MS with CAD. Preoperative pulmonary artery pressure, pulmonary capillary wedge pressure, and cardiac index were not different among groups, but patients with MR and CAD had a significantly higher left ventricular end-diastolic pressure (LVEDP) and a significantly lower ejection fraction than other groups. Mortality was 7.1% for patients with MS, 5.4% for MR, 8.1% for mixed MS and MR, 0 for MS with CAD, and 21.7% for MR and CAD. Overall mortality was 9.2%. Eleven patients had emergency operations for cardiogenic shock with a mortality of 45%. Nineteen additional patients in New York Heart Association (NYHA) Functional Class IV had MVR or MVR plus CABG with a mortality of 26%. Sixteen patients required intraaortic balloon pump assistance, and 9 survived. Four patients with MR and CAD required the left ventricular assist device, and 3 survived. Excluding patients who had emergency operations, overall mortality was 5.8%. Excluding patients who had emergency operations and patients in NYHA Functional Class IV, overall mortality was 2%. Factors associated with death were cardiogenic shock, NYHA Class IV, LVEDP greater than 15 mm Hg (16% mortality), and age greater than 60 years (15% mortality).

UR - http://www.scopus.com/inward/record.url?scp=0022198224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022198224&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(10)62628-8

DO - 10.1016/S0003-4975(10)62628-8

M3 - Article

C2 - 3872643

AN - SCOPUS:0022198224

VL - 39

SP - 346

EP - 352

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 4

ER -